ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

HALB Halberd Corp (PK)

0.00794
-0.00056 (-6.59%)
May 06 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 1,056,447
Bid Price 0.0076
Ask Price 0.0083
News -
Day High 0.0085

Low
0.003

52 Week Range

High
0.0122

Day Low 0.0076
Company Name Stock Ticker Symbol Market Type
Halberd Corp (PK) HALB OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.00056 -6.59% 0.00794 16:00:06
Open Price Low Price High Price Close Price Prev Close
0.0076 0.0076 0.0085 0.00794 0.0085
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
43 1,056,447 $ 0.008111 $ 8,569 - 0.003 - 0.0122
Last Trade Time Type Quantity Stock Price Currency
16:00:33 formt 456,602 $ 0.008072 USD

Halberd Corp (PK) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
5.66M 565.87M 280.54M 3k -454k -0.00 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Halberd (PK) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No HALB Message Board. Create One! See More Posts on HALB Message Board See More Message Board Posts

Historical HALB Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.008120.00890.00760.0085146428,794-0.00018-2.22%
1 Month0.009060.00910.00740.0083889573,045-0.00112-12.36%
3 Months0.0110.01210.0060.00883931,140,159-0.00306-27.82%
6 Months0.00720.01210.0030.00760871,302,3050.0007410.28%
1 Year0.00950.01220.0030.00805581,077,697-0.00156-16.42%
3 Years0.03760.0530.0030.02478872,492,428-0.02966-78.88%
5 Years0.00140.1090.00040.02898014,895,1640.00654467.14%

Halberd (PK) Description

Halberd Corp is a research-based company seeking to develop treatments for a range of diseases. Their extracorporeal method treats blood-borne, neurologic and infectious diseases. Halberd's patents remove bodily fluids in a continuous fashion, like dialysis, or in a batch process. To treat the specific disease, the treatment is applied to the bodily fluid. Disease eradication via exposure to radio frequency, laser irradiation, or chemical bonding. The cleansed bodily fluids are then returned to the patient without deadly side effects found with injected or ingested medications. Halberds technology base is 4 issued patents and 22 pending patents: Current projects with planned submissions of abstracts to ARPA-H include: * Extracorporeal eradication of inflammatory cytokines from cerebrospinal fluid associated with PTSD and Suicidal Ideation * Therapeutic lozenges to alleviate pain and anxiety as well as chemical and alcohol addiction * Eradication of antibiotic-resistant bacteria and deadly Candida Auris fungi supplied by CDC * Development of a nasal spray is in pre-clinical testing designed to eliminate neurodegenerative cascade associated of head trauma * Extracorporeal eradication of antigens associated with cancer * Extracorporeal eradication of the 10 inflammatory cytokines & the excitatory neurotransmitter associated with Alzheimer's Disease, Parkinson's Disease & Epilepsy * Development of antibodies against Coronavirus & extracorporeal eradication of Covid antigens.

Your Recent History

Delayed Upgrade Clock